Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Gilead's Harvoni Receives Notice of Compliance from Canada
Yahoo/Zacks.com
Fri, 10/17/14 - 07:08 pm
Gilead Sciences
Harvoni
hepatitis C
Canada
Should Gilead Sciences, inc. Fear Incoming Competition?
Motley Fool
Wed, 10/15/14 - 02:51 pm
Gilead Sciences
hepatitis C
AbbVie
Bristol-Myers Squibb
Gilead Sciences Falls Amid Worries Over Hep-C Drug Price
TheStreet.com
Tue, 10/14/14 - 11:22 am
Gilead Sciences
hepatitis C
drug pricing
Harvoni
If AbbVie Discounts its Hep C Drug, Would Pricing Reach a Tipping Point?
WSJ Pharmalot
Tue, 10/14/14 - 09:51 am
AbbVie
drug pricing
hepatitis C
Gilead Sciences
The Gilead Effect
The Morning Consult
Tue, 10/14/14 - 08:38 am
Gilead Sciences
drug pricing
Sovaldi
Companies That Could Develop An Enterovirus Treatment
Yahoo/Benzinga
Mon, 10/13/14 - 09:16 am
enterovirus
AbbVie
Alnylam
Gilead Sciences
Bristol-Myers Squibb
Merck
Biocryst
Chimerix
Tekmira
Sarepta Therapeutics
Gilead Wins U.S. Approval for Hepatitis C Combo Pill
Bloomberg
Fri, 10/10/14 - 05:51 pm
Gilead Sciences
FDA
Harvoni
hepatitis C
As Hepatitis Pill Harvoni Joins Sovaldi, States Erect Medicaid Hurdles
Forbes
Fri, 10/10/14 - 09:10 am
Harvoni
Sovaldi
Medicaid
hepatitis C
Gilead Sciences
Does Gilead Sciences Have a European Problem?
Barron's
Wed, 10/8/14 - 01:07 pm
Gilead Sciences
Europe
Sovaldi
Gilead Sciences: Here Comes the Competition
Barron's
Tue, 10/7/14 - 01:21 pm
Gilead Sciences
hepatitis C
Sovaldi
Merck
AbbVie
Idenix
Bristol-Myers Squibb
Achillion
Sovaldi may be cost-effective, but the U.K. can't afford it, documents say
Fierce Pharma
Tue, 10/7/14 - 08:09 am
Sovaldi
UK
drug pricing
Gilead Sciences
hepatitis C
Will Biotech Beat This Earnings Season?
Barron's
Mon, 10/6/14 - 06:05 pm
earnings
Gilead Sciences
Celgene
Biogen Idec
Gilead Outperforms Biotech Sector Over Success Of Sovaldi, Harvoni, And Zydelig
Bidness Etc.
Mon, 10/6/14 - 07:42 am
Gilead Sciences
Sovaldi
Harvoni
Zydelig
Biopharmaceutical companies are now increasingly relocating patent rights to overseas markets to lower their tax burden
Bidness Etc.
Wed, 10/1/14 - 08:09 am
tax inversions
intellectual property
Gilead Sciences
Alexion
Pharma Events To Watch Out For This Week
Bidness Etc.
Mon, 09/29/14 - 01:15 pm
Salix
Progenics
Relistor
AASLD
Merck
Gilead Sciences
AbbVie
Intercept Pharma
Gilead's HIV Drugs Tybost and Vitekta Get FDA Clearance
Yahoo/Zacks
Sat, 09/27/14 - 09:31 am
Gilead Sciences
Tybost
Vitekta
HIV
Can Gilead Sciences Be A Do-Gooder And Still Do Well?
Investor's.com
Sat, 09/27/14 - 09:23 am
Gilead Sciences
Sovaldi
Gilead’s Hepatitis C Combination Wins EU Agency Backing
Bloomberg
Fri, 09/26/14 - 09:02 am
Gilead Sciences
hepatitis C
Europe
Sovaldi
ledipasvir
Gilead, Celgene Key Holdings Of Top Health Care Fund
Investors.com
Fri, 09/26/14 - 09:01 am
Gilead Sciences
Celgene
Generic Sovaldi makers could pocket upwards of $600m says analyst
In-Pharma Technologist
Thu, 09/25/14 - 09:25 am
generics
Sovaldi
Gilead Sciences
hepatitis C
Mylan
Strides Arcolab
Cadila
Cipla
Hetero Labs
Ranbaxy
Sequent Scientific
Pages
« first
‹ previous
…
69
70
71
72
73
74
75
76
77
…
next ›
last »